A beta-blocker and aspirin combination may help attenuate the heightened CVD risk observed in people who have recently lost a loved one, according to research published in the American Heart Journal in February.

Over half of heart patients on a triple-drug regimen of ACE inhibitors, statins and either calcium channel blockers or aspirin are nonadherent to their medications, researchers reported in the American Journal of Cardiology Feb. 6.

A 90-second chest scan could be a game-changer for triaging patients who present to the emergency department with undiagnosed chest pain, according to research out of Detroit.

Amarin on Jan. 13 announced the launch of True to Your Heart, a new educational campaign geared toward heart patients who remain at a persistent risk for CVD despite being treated with statins and other standard-of-care therapies.

An analysis of 12 recent randomized clinical trials suggests a majority of patients with ischemic heart disease or a history of MI are eligible for new secondary prevention therapies—a finding that, if acted upon, could change a paradigm that’s been in place for decades.

Research out of Norway suggests obesity, high blood pressure and diabetes could have a lot to do with CVD’s tendency to present later in life in women than in men.

A study published in JAMA Cardiology Jan. 2 suggests physicians may achieve comparable results when using either radial or femoral access for primary PCI in patients with STEMI.

Surgical candidates with active cannabis use disorders were nearly twice as likely as their non-user peers to suffer a heart attack after surgery, according to research published in Anesthesiology on Nov. 25.